| Literature DB >> 21609003 |
Stacey L Harper1, Jason Lee Carriere, John M Miller, James Evan Hutchison, Bettye L S Maddux, Robert L Tanguay.
Abstract
The challenge of optimizing both performance and safety in nanomaterials hinges on our ability to resolve which structural features lead to desired properties. It has been difficult to draw meaningful conclusions about biological impacts from many studies of nanomaterials due to the lack of nanomaterial characterization, unknown purity, and/or alteration of the nanomaterials by the biological environment. To investigate the relative influence of core size, surface chemistry, and charge on nanomaterial toxicity, we tested the biological response of whole animals exposed to a matrix of nine structurally diverse, precision-engineered gold nanoparticles (AuNPs) of high purity and known composition. Members of the matrix include three core sizes and four unique surface coatings that include positively and negatively charged headgroups. Mortality, malformations, uptake, and elimination of AuNPs were all dependent on these parameters, showing the need for tightly controlled experimental design and nanomaterial characterization. Results presented herein illustrate the value of an integrated approach to identify design rules that minimize potential hazard.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21609003 PMCID: PMC3124923 DOI: 10.1021/nn200546k
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881
Figure 3Dose–response results of embryonic zebrafish screen for tested AuNPs. (a) Percentage of zebrafish exhibiting either mortality or any malformation for each size and ligand tested across a spectrum of concentrations compared to control. (b) Examples of malformations seen upon exposure to 0.8 nm MES-AuNPs scored in the malformation category compared to 0 ppm control embryo. (c) Percentage of zebrafish dying after exposure to the library of AuNPs. (d) Percentage of zebrafish that survive, but showing some malformation or behavioral abnormality. Significance was determined by the Fisher exact test, *p < 0.05, **p < 0.01 compared to control.
Figure 4Quantification by INAA of gold in zebrafish embryos exposed to AuNPs. (a) Instrument neutron activation analysis was used to quantify the mass of Au in individual embryos (N = 3) exposed to 0.8, 1.5, or 10 nm AuNPs. The effect of exposure duration on bioaccumulation of Au was tested using ANOVA (**p < 0.001, *p < 0.05). Where significant differences were identified, pairwise comparisons were performed using the Tukey test. Dunn’s ANOVA test on ranks was used when equal variance assumptions were violated. (b) Uptake and elimination rates for AuNPs in embryonic zebrafish. Rates were calculated as the mass of gold (ng) divided by the duration (hours) for embryos exposed to 50 ppm AuNPs functionalized with MEE, MES, or MEEE and 0.4 ppm AuNPs functionalized with TMAT. Values above the line indicate uptake, and values below the line indicate elimination.
Raw Data for Quantity of AuNPs Found in Embryonic Zebrafish As Determined by INAAa
| quantification of Au in ng | mean number of AuNPs | |||||||
|---|---|---|---|---|---|---|---|---|
| surface groups | core size (nm) | ng Au avail. | 24 hpf | 48 hpf | 120 hpf | 24 hpf | 48 hpf | 120 hpf |
| MEE | 0.8 | 2.2 × 104 | 50 ± 2(0.23) | 70 ± 5(0.31) | 0(0) | 1.4 × 1013 | 1.9 × 1013 | 0.0 |
| 1.5 | 2.9 × 104 | 187 ± 29(0.65) | 141 ± 37(0,49) | 3 ± 4 (0.01) | 5.7 × 1012 | 4.3 × 1012 | 9.1 × 1010 | |
| MES | 0.8 | 3.2 × 104 | 94 ± 52 (0.29) | 190 ± 20(0,59) | 0(0) | 2.6 × 1013 | 5.3 × 1013 | 0.0 |
| 1.5 | 4.2 × 104 | 113 ± 13 (0.27) | 324 ± 35(0,76) | 4 ± 1(0.01) | 3.4 × 1012 | 9.8 × 1012 | 1.2 × 1011 | |
| MEEE | 0.8 | 2.3 × 104 | 102 ± 60(0.44) | 150 ± 31 (0.65) | 3 ± 4 (0.01) | 2.8 × 1013 | 4.2 × 1013 | 8.3 × 1011 |
| 1.5 | 2.5 × 104 | 74 ± 12(0.29) | 84 ± 5 (0.34) | 1 ± 0(0.01) | 2.2 × 1012 | 2.5 × 1012 | 3.0 × 1010 | |
| TMAT | 0.8 | 2.8 × 101 | 6.8 ± 3.0(24.46) | 7,6 ± 1.2 (27.60) | 5.7 ± 0.6 (20,59) | 1.9 × 1012 | 2.1 × 1012 | 1.6 × 1012 |
| 1.5 | 3.3 × 101 | 5.2 ± 0.7(16.06) | 5.8 ± 0.4 (17.72) | 11.1 ± 3(34,39) | 1.6 × 1011 | 1.8 × 1011 | 3.4 × 1011 | |
| 10 | 3.8 × 101 | 1.2 ± 0.2(3.12) | 2.2 ± 0.3(5.83) | 1.7 ± 0.6 (4.5) | 9.9 × 107 | 1.8 × 108 | 1.4 × 108 | |
The data presented in this table show that while the total quantity of TMAT-AuNPs taken up by the embryos was quite small, it was by far the greatest uptake compared to other ligands as a percentage of total available AuNPs in the exposure.